|
Real-time Estimate
Cboe BZX
22:36:54 03/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.1820 USD | -2.15% |
|
-10.15% | -69.33% |
| 08-20 | Top Premarket Decliners | MT |
| 08-14 | Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
CBOEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| MTNB | Delayed | |
CBOE
| MTNB | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.241 | 0.3565 | 0.7553 |
| Spread/Res. | -25.44% | -49.59% | -76.21% |
| Spread/Supp. | -1.53% | -1.53% | +124.91% |
| Support | 0.1825 | 0.1825 | 0.0799 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MTNB Stock
- Charts Matinas BioPharma Holdings, Inc.
Select your edition
All financial news and data tailored to specific country editions
